QIAGEN Transfers Distribution Rights for Transplantation Testing Product Portfolio and Related Assets to LinkMed
Transaction allows QIAGEN to increase focus on personalized medicine applications of HLA testing products
18-Jun-2009 -
QIAGEN N.V. announced that it has signed an agreement to transfer distribution rights for the Olerup SSP product line and the related assets to Olerup International AB, a subsidiary of LinkMed, a Swedish venture capital company specializing in Life Sciences.
The Olerup SSP product line includes ...
AIDS
Life Sciences
medicine
+1